Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-18-143297
Filing Date
2018-04-30
Accepted
2018-04-30 16:30:04
Documents
6
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d556004d10ka.htm 10-K/A 486907
2 EX-31.1 d556004dex311.htm EX-31.1 2972
3 EX-31.2 d556004dex312.htm EX-31.2 2932
4 GRAPHIC g556004g0427112836660.jpg GRAPHIC 778
5 GRAPHIC g556004g0427112836769.jpg GRAPHIC 800
6 GRAPHIC g556004g0427112837717.jpg GRAPHIC 7175
  Complete submission text file 0001193125-18-143297.txt   506507
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 617-259-1970
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33038 | Film No.: 18790245
SIC: 2834 Pharmaceutical Preparations